SCHEDULE 13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 1, 2005

Accession Number

0000950123-05-004013

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →